HomeGTBP • NASDAQ
add
GT Biopharma Inc
Previous close
$3.04
Day range
$2.86 - $3.01
Year range
$1.92 - $10.66
Market cap
6.41M USD
Avg Volume
26.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.60M | 15.44% |
Net income | -3.41M | -41.18% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.42M | -59.92% |
Total assets | 6.76M | -58.14% |
Total liabilities | 4.66M | -24.11% |
Total equity | 2.10M | — |
Shares outstanding | 2.23M | — |
Price to book | 3.23 | — |
Return on assets | -112.44% | — |
Return on capital | -236.95% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -3.41M | -41.18% |
Cash from operations | -2.74M | -39.36% |
Cash from investing | -1.00K | -100.05% |
Cash from financing | 0.00 | — |
Net change in cash | -2.74M | -2,200.84% |
Free cash flow | -1.67M | -49.43% |
About
Founded
1965
Headquarters
Website
Employees
2
